Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

Clinical trial NCT05969158 · UNKNOWN

Trial details

NCT number: NCT05969158
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Thrombocytopenia

Start date: 2023-09-04
Primary completion: 2025-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.